Zhengzhou Tairong Industrial Investment Co., Ltd. completed the acquisition of 14.37% stake in Henan Taloph Pharmaceutical Stock Co.,Ltd from Zhengzhou Zhongsheng Industrial Group Co., Ltd.
January 20, 2022
Share
Zhengzhou Tairong Industrial Investment Co., Ltd. signed an agreement to acquire 14.37% stake in Henan Taloph Pharmaceutical Stock Co.,Ltd (SHSE:600222) from Zhengzhou Zhongsheng Industrial Group Co., Ltd. for approximately CNY 800 million on November 29, 2021. As per the transaction, Zhengzhou Tairong Industrial Investment Co., Ltd. will acquire 82.44 million shares at CNY 9.70 per share. This transaction still needs to pass the review of the concentration of undertakings and obtain the review and approval of the competent state-owned authority. The transfer of the share agreement still needs to go through the compliance confirmation of the Shanghai Stock Exchange and apply for the registration of the transfer of shares.
Zhengzhou Tairong Industrial Investment Co., Ltd. completed the acquisition of 14.37% stake in Henan Taloph Pharmaceutical Stock Co.,Ltd (SHSE:600222) from Zhengzhou Zhongsheng Industrial Group Co., Ltd. on January 21, 2022. Post completion, Zhengzhou Zhongsheng Industrial Group Co., Ltd. will hold 50 million shares representing 8.71% stake of Henan Taloph Pharmaceutical Stock Co.,Ltd
HENANTALOPHPHARMACEUTICALSTOCKCO., LTD is a China-based company principally engaged in the research and development, manufacture and sales of pharmaceuticals. The Company provides oral solutions, transfusion and tablets, which are applied in the treatment of cold, diabetes and virus infection. The Company's main products include Shuanghuanglian oral liquid products, double gold agents, Haberffine tablets and compound Yimu oral solutions, among others. The Company distributes its products mainly within domestic market.
Zhengzhou Tairong Industrial Investment Co., Ltd. completed the acquisition of 14.37% stake in Henan Taloph Pharmaceutical Stock Co.,Ltd from Zhengzhou Zhongsheng Industrial Group Co., Ltd.